Disease
|
Drug/Important Bio-Agent (IBA)
| 2 | Retinaldehyde (Retinal)IBA
03/2003
-
12/2002 |
| 1 | Raloxifene Hydrochloride (Evista)FDA Link
11/2012 |
| 1 | 2,4-thiazolidinedione (thiazolidinedione)IBA
06/2011 |
| 1 | Glucagon-Like Peptide-1 ReceptorIBA
06/2011 |
| 1 | Exenatide (Byetta)FDA Link
06/2011 |
| 1 | BiguanidesIBA
06/2011 |
| 1 | bunazosin (Andante)IBA
02/2005 |
| 1 | EstersIBA
12/2003 |
| 1 | AFP-157IBA
12/2003 |
| 1 | Melanins (Melanin)IBA
12/2003 |
| 1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoic acid (5Z)-7-((1R,2RIBA
12/2003 |
| 1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoate 1-methyl (5Z)-7-((1R,2RIBA
12/2003 |
| 1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoate 1-ethyl (5Z)-7-((1R,2RIBA
12/2003 |
| 1 | Carboxylic AcidsIBA
12/2003 |
| 1 | tafluprostIBA
12/2003 |
| 1 | Latanoprost (Xalatan)FDA Link
12/2003 |
| 1 | Topiramate (Topamax)FDA LinkGeneric
03/2003 |
| 1 | Timolol (Blocadren)FDA LinkGeneric
12/2002 |
| 1 | Glutamic Acid (Glutamate)FDA Link
12/2002 |
|
Therapy/Procedure
|